Sign In
NewsRadar

Ganymed Pharmaceuticals

GANYMED´s core competencies revolve around identifying key disease associated molecules and developing them towards specific immunotherapeutics.

• Show past press releases
• Edit this company

Contact Information
Address:
 
 
Phone:
Fax:
Web:
Contact:
 
 
Freiligrathstrasse 12
Mainz 55131
Germany
+49 (0)6131 1440 100
+49 (0)6131 1440 111
http://www.ganymed-pharmaceuticals.com
Dr. med. Özlem Türeci
+49 (0)6131 1440 100

Company Facts
Founded:
Founders:Ugur Sahin, Özlem Türeci, Burkhard Ludewig, Christoph Huber, Rolf Zinkernagel, Hans Hengartner
CEO:Özlem Türeci
CTO or technical lead:Özlem Türeci
CFO or finance director:Dirk Sebastian
Head of Sales:
Head of Marketing:Rainer Wessel

Stage:Growth
Category:Biotechnology & Healthcare
Sector:Biopharmaceuticals
Employees:20
Profitability:Pre-revenue
Funding raised:Yes
Funding sought:Yes
Seeking Partnerships:No

Non-executive Board Members

  • Felix Hofstetter
  • Prof. Dr. Christoph Huber
  • Prof. Dr. Rolf Krebs
  • Dr. John Ryan
  • Dr. Harald Poth
  • Dr. Björn Hoffstedt

    Key Customers

    Key Business Partners

    Key Competitors

    Capital Raised
    DateSizeInvestors
    To view this information you must be signed in and subscribed to the online dataservice, sign in here.

    To read more about the Online data service click here

    Public Offerings
    DateTypeExchange
    No public offerings


  • Data


    24,583
    Tech investments
    From our Online Data Service
    15,902
    VC-backed companies
    From our Radar


    Recent Deals


    DATEAMOUNTSECTOR
    Aug 10€19.0MBusiness applications
    Aug 10N/APayment software
    Aug 10€1.4MInternet services
    Aug 10€0.8MPayment software
    Aug 10€3.7MArtificial Intelligence
    Aug 10€73.0MBiopharmaceuticals
    Aug 9€11.4MWireless applications

    For information on Europe's most extensive database on technology funding click here!

    Events



    Press Releases


    Mar 29
    Addex Therapeutics
    addex sucessfully raises chf40 million in capital increase

    Jan 2
    Urban Jungle
    urban jungle raises £1m in seed funding to build tech-enabled home ...

    Aug 17
    Komed Health
    komed health closes seed financing round

    Jul 10
    Komed Health
    komed health to be supported by nokia and deutsche telekom

    May 4
    Vivet Therapeutics
    vivet therapeutics raises €37.5 million in series a





    About usContact usLegal Information
    Copyright © 1999-2018
    Emerging Technology Research Europe Inc. All rights reserved.